Latest news
Jennifer Taubert announces retirement from J&J; Takeda’s global TYK2 leader exits - Endpoints NewsEndpoints News · Fri, 07 Aug 2026 11:00:00 GMTReplimune melanoma drug snags coveted FDA approval after yearlong clash, two rejections - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 20:03:00 GMTGreg Verdine’s LifeMine raises $263M for safer immunosuppressant - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 10:30:00 GMTLet the orexin market begin: Takeda snags FDA approval for narcolepsy type 1 drug - Endpoints NewsEndpoints News · Wed, 05 Aug 2026 21:34:58 GMTDemis Hassabis says he's 'leaning into' Isomorphic role amid Alphabet and DeepMind shakeup - Endpoints NewsEndpoints News · Wed, 05 Aug 2026 18:11:00 GMTHinge Health will buy Cylinder Health for $105M to enter digestive care - Endpoints NewsEndpoints News · Tue, 04 Aug 2026 20:15:00 GMTPfizer keeps cutting, eliminating costs and programs as pipeline delivers mixed results - Endpoints NewsEndpoints News · Tue, 04 Aug 2026 11:36:00 GMTExclusive: Pathos AI signs two deals, plans to raise Series E at $3B valuation - Endpoints NewsEndpoints News · Tue, 04 Aug 2026 00:00:00 GMT